Tag : Congruence Therapeutics

Clinical Research, Pharma & Healthcare Financing

Congruence Raises $39.5M to Advance Small Molecule Therapies

PR Newswire
by PR Newswire016
– Phase 1/1b clinical trial with CGX-926 ongoing for MC4R-deficient genetic obesity – – Programs in Parkinson’s Disease and Alpha-1 antitrypsin deficiency progressing toward the clinic...